? CANCER RESEARCH TRAINING AND EDUCATION COORDINATION The Center for Cancer Mentoring, Education, Leadership, and Oncology-related Training (CAMELOT) serves as the centralized hub for the Ohio State University Comprehensive Cancer Center (OSUCCC) fostering cancer research and education, and disseminating those opportunities. CAMELOT?s efforts begin at the high school level, continue through undergraduate and graduate training, and then extend through post-doctoral training and into early faculty development and mentoring. CAMELOT is directed by Dr. Lawrence Kirschner, the OSUCCC Associate Director of Training and Education. He is assisted by Drs. Deepa Sampath, Elizabeth Klein, and Rosa Lapalombella. CAMELOT coordinates training and education programs through: 1) direct programs (e.g., for high school, Pelotonia fellows, external undergraduate student summer rotations including students from Ohio Historically Black Universities and Colleges); 2) integrating College of Medicine (COM) programs with OSUCCC activities and opening them to trainees and junior faculty outside the COM; 3) supporting grant submissions by junior faculty; and 4) supporting training grant submissions. The Pelotonia Fellowship Program (PFP), a major commitment by the OSUCCC to fellowship training, has been in existence for 10 years, and provides stipends and research support to fellows from the undergraduate to the postdoctoral fellowship level. OSUCCC provides $2-3M/year to support the PFP. During the current grant cycle, 251 pre- and postdoctoral fellowships awarded, of which 155 had mentors who were OSUCCC members from all five of the OSUCCC research programs and 10 of the 15 OSU Colleges. More than 90% of these trainees are currently active as cancer researchers. New programs developed by CAMELOT include two cancer research-focused pipeline programs, one for local underrepresented minority high school students and another for current OSU undergraduates.
The Specific Aims are to: 1) provide integration and coordination of training opportunities for cancer research across the OSUCCC and university ecosystem, and region, including high schools and colleges; 2) enhance formalized programming for cancer-based mentoring including both peer-to-peer and senior-to-junior mentoring; and, 3) develop an integrated system to enable assessment and outcome tracking for trainees at all levels of engagement with the OSUCCC (grants, papers, academic positions, etc.) to foster continuous quality improvement in educational and career development activities. The OSUCCC is planning robust faculty recruitment around strategic research priorities that will create new opportunities for education and training. To accommodate this, a bigger pipeline for training is planned in the next funding cycle. The OSUCCC will: 1) expand graduate and postgraduate training slots and programs for high school students; 2) establish the Young Cancer Investigator Faculty Academy that focuses on OSUCCC wet-lab researchers to support development of independent research programs; 3) establish a uniform tracking system for trainees; and 4) foster submissions of R25 and T32 training grants, including supplements.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016058-45
Application #
10089992
Study Section
Subcommittee H - Clinical Groups (NCI)
Project Start
1997-09-12
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Moshiri, Jasmine; Kaur, Darpan; Hambira, Chido M et al. (2018) Identification of a Small Molecule Anti-biofilm Agent Against Salmonella enterica. Front Microbiol 9:2804
Serna, Vanida A; Wu, Xin; Qiang, Wenan et al. (2018) Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo. Endocr Relat Cancer 25:747-759
Dabrowski, Konrad; Miller, Mackenzie (2018) Contested Paradigm in Raising Zebrafish (Danio rerio). Zebrafish 15:295-309
Krok-Schoen, Jessica L; Fisher, James L; Baltic, Ryan D et al. (2018) White-Black Differences in Cancer Incidence, Stage at Diagnosis, and Survival Among Older Adults. J Aging Health 30:863-881
Killian, Jackson A; Topiwala, Taha M; Pelletier, Alex R et al. (2018) FuSpot: a web-based tool for visual evaluation of fusion candidates. BMC Genomics 19:139
Sizemore, Gina M; Balakrishnan, Subhasree; Thies, Katie A et al. (2018) Stromal PTEN determines mammary epithelial response to radiotherapy. Nat Commun 9:2783
Zeng, Rong; Liu, Yi; Jiang, Zhao-Jing et al. (2018) EPB41L3 is a potential tumor suppressor gene and prognostic indicator in esophageal squamous cell carcinoma. Int J Oncol :
Kotlarek, Marta; Kubiak, Anna; Czetwerty?ska, Ma?gorzata et al. (2018) The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma. Int J Mol Sci 19:
Li, Feng; Malli, Ahmad; Cruz-Monserrate, Zobeida et al. (2018) Confocal endomicroscopy and cyst fluid molecular analysis: Comprehensive evaluation of pancreatic cysts. World J Gastrointest Endosc 10:1-9
He, Huiling; Li, Wei; Yan, Pearlly et al. (2018) Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma. Thyroid 28:748-754

Showing the most recent 10 out of 2602 publications